Glenn van Dael
Director/Board Member at Rejuvenate Biomed
Glenn van Dael active positions
Companies | Position | Start | End |
---|---|---|---|
Rejuvenate Biomed
Rejuvenate Biomed Medical/Nursing ServicesHealth Services Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation. | Director/Board Member | - | - |
Career history of Glenn van Dael
Former positions of Glenn van Dael
Companies | Position | Start | End |
---|---|---|---|
CMAST BV
CMAST BV Miscellaneous Commercial ServicesCommercial Services CMAST BVBA engages in the provision of project management, consulting, and business solutions. It offers strategic collaborations, research and development, supply chain and operations, and information technology services. The company was founded by Glenn Van Dael and Nadia De Wilde in 2008 and is headquartered in Temse, Belgium. | Chief Executive Officer | 2007-12-31 | - |
Founder | 2007-12-31 | - |
Statistics
International
Belgium | 3 |
Operational
Chief Executive Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sectoral
Commercial Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
CMAST BV
CMAST BV Miscellaneous Commercial ServicesCommercial Services CMAST BVBA engages in the provision of project management, consulting, and business solutions. It offers strategic collaborations, research and development, supply chain and operations, and information technology services. The company was founded by Glenn Van Dael and Nadia De Wilde in 2008 and is headquartered in Temse, Belgium. | Commercial Services |
Rejuvenate Biomed
Rejuvenate Biomed Medical/Nursing ServicesHealth Services Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation. | Health Services |
- Stock Market
- Insiders
- Glenn van Dael
- Experience